Sitemap

Dental Disturbance Classification and Severity Rating Scale of Sonis et al Following Cranial Radiation Therapy in Pediatric Acute Lymphoblastic Leukemia

Predictors of Robien et al for Oral Mucositis in a Patient with CML Undergoing Hematopoietic Cell Transplantation

Oral Evaluation and Mucositis Grading of Seto et al in a Patient Following Bone Marrow Transplantation

Clinical Features of Dirix et al for Radiation-Induced Xerostomia in a Patient with Cancer of the Head and Neck

Risk Factors of Rask et al for Oral Mucositis in a Child Treated with High-Dose Methotrexate

Risk Factors of Smith et al for Aspiration Following Free Flap Reconstruction Following an Oral Cavity or Oropharyngeal Tumor Resection

Classification of Yoshioka et al for Tongue Hemiatrophy Following Brachytherapy for Tongue Cancer

Risk Factors of Kaste et al for Dental Abnormalities Following Radiation and Chemotherapy for a Pediatric Cancer

Risk Factors of Suarez-Cunqueiro et al for Speech and Swallowing Difficulties Following Therapy of an Oral or Oropharyngeal Cancer

Dental and Salivary Gland Complications of Cyclophosphamide Therapy in Pediatric Patients with Cancer

Interventions to Help Manage a Patient with Oral Mucositis

Risk Factors of Grazziutti et al for Severe Oral Mucositis in a Patient Undergong Melphalan-Based Autologous Stem Cell Transplant for Myeloma

Grading Systems of Eisbruch et al for Radiotherapy-Induced Xerostomia

RTOG/EORTC Criteria for Lung Complications to Irradiation

RTOG/EORTC Criteria for Laryngeal Complications to Irradiation

SOMA-LENT Scoring of Laryngeal Complications Following Cancer Therapy

SOMA-LENT Scoring of Pulmonary Complications Following Cancer Therapy

Common Toxicity Criteria (CTC) for Pulmonary Complications Associated with Cancer Therapy

Screening Questionnaire of van Gogh et al for Voice Impairment After Treatment of Early Glottic Cancer

Definition of the Idiopathic Pneumonia Syndrome (IPS) Following Bone Marrow or Allogeneic Stem Cell Transplantation

Risk Factors for Idiopathic Pneumonia Syndrome Following Bone Marrow or Allogeneic Stem Cell Transplantation

Clinical Features of Diffuse Alveolar Hemorrhage (DAH) Following Bone Marrow or Allogeneic Stem Cell Transplantation

Clinical Features of Periengraftment Respiratory Distress Syndrome (PERDS) Following Stem Cell Transplantation

Risk Factors of Wall and Schnapp for Radiation-Induced Lung Injury

Clinical Features of Wall and Schnapp for Radiation Pneumonitis

Cytotoxic Lung Injury Associated with Bleomycin

Cytotoxic Lung Injury Associated with Busulfan

Risk Factors of Haugnes et al for Restrictive Lung Disease in a Long-Term Survivor of Testicular Cancer

Risk Factors of Ando et al for Interstitial Lung Disease Following Therapy with Gefitinib in a Patient with Non-Small Cell Lung Cancer

Risk Factors of Al Ameri et al for Acute Pulmonary Failure During Remission Induction Chemotherapy for Acute Myeloid Leukemia or High-Risk Myelodysplasia

Pulmonary Arterial Hypertension Associated with Dasatinib (Sprycel) Therapy

Equation and Nomogram of Bradley et al for Predicting Radiation Pneumonitis

Risk Factors for Pulmonary Toxicity Associated with Erlotinib Therapy

Risk Factors for Pulmonary Toxicity Associated with Gemcitabine Therapy

Risk Factors for Pulmonary Toxicity Associated with Taxane Therapy

RTOG/EORTC Criteria for Cardiac Complications from Irradiation

SOMA-LENT Scoring of Vascular Complications Following Cancer Therapy

SOMA-LENT Scoring of Cardiac Complications Following Cancer Therapy

Common Toxicity Criteria (CTC) for Cardiac Arrhythmias Associated with Cancer Therapy

Common Toxicity Criteria (CTC) for Lymphatic Complications Associated with Cancer Therapy

Common Toxicity Criteria (CTC) for Cardiovascular Complications Associated with Cancer Therapy

Delayed Radiation-Induced Changes in Arteries

Venous Sclerosis Following Infusion of a Chemotherapeutic Agent

Recommendations of Patel et al for Evaluating a Patient for Atherosclerotic Vascular Disease Following Moderate to High Dose Radiation Therapy

Risk Factors of Hancock et al for Late Cardiac Mortality Following Mediastinal Irradiation for Hodgkin's Disease

Arterial Thromboembolism Associated with Bevacizumab Therapy

Risk Factors for Cardiotoxicity Following Doxorubicin Therapy

Electron Microscopic Grading of Doxorubicin Cardiotoxicity

Risk Factors of Armenian et al for Late Congestive Heart Failure Following a Hematopoietic Cell Transplant

Heart Failure Associated with Sunitinib Malate Therapy

Conversion Factors of Keefe et al for Comparing Cardiotoxicity of Various Anthracyclines

Algorithm of Keefe for Monitoring a Patient Receiving an Anthracycline

Risk Factors for Cardiomyopathy in a Patient with Down's Syndrome Following Anthracycline Chemotherapy

Hypertension During Treatment with a Vascular Endothelial Growth Factor (VEGF) Signal Inhibitor

Adjuvant Cardiac Review and Evaluation Committee (ACREC) Criteria for Symptomatic Heart Failure Associated with Adjuvant Chemotherapy

Cardiac Toxicity and Heart Failure Associated with Bevacizumab Therapy

Risk for Coronary Artery Stenosis Following Radiation Therapy for Breast Cancer

Questionnaire for Bowel Symptoms After Radiation Therapy for Prostate Cancer

RTOG/EORTC Criteria for Complications to Irradiation in the Pharynx and Esophagus

RTOG/EORTC Criteria for Intestinal Complications from Irradiation

Radiation Proctitis Symptom Scale of Kennedy et al

SOMA-LENT Scoring of Gastric Complications to Cancer Therapy

Risk Factors for Intestinal Injury Following Radiation Therapy

SOMA-LENT Scoring of Esophageal Complications Following Cancer Therapy

SOMA-LENT Scoring of Rectal Complications Following Cancer Therapy

SOMA-LENT Scoring of Complications Involving the Small Intestine and Colon Following Cancer Therapy

WHO Criteria for Acute and Subacute Gastrointestinal Toxic Effects of Cancer Therapy in Adults

Esophageal Stricture Following Radiotherapy for Head and Neck Carcinoma

Recommendations of Waddell et al for Prevention of Chronic Radiation Enteritis

Common Toxicity Criteria (CTC) for Gastrointestinal Adverse Events Associated with Cancer Therapy

Risk Factors of Maguire et al for Late Esophageal Toxicity After High Dose Conformal Radiation Therapy for Lung Carcinoma

Daily Gut Score of Blijlevens et al for Gastrointestinal Toxicity Associated with Cancer Therapy

Monitoring Serum Citrulline Concentrations as a Measure of Small Bowel Toxicity Secondary to Myeloablative Therapy

Recommendations for Management of Chemotherapy-Induced Diarrhea in a Patient Receiving Irinotecan, Fluorouracil, and Leucovorin (IFL) Regimen

Criteria for Complicated and Uncomplicated Chemotherapy-Induced Diarrhea

Gastrointestinal Perforation Associated with Bevacizumab Therapy

Hiccups Associated with Cancer Chemotherapy

Risk Factors of Covens et al for a Patient with Radiation-Induced Bowel Injury Requiring Surgical Management

Modified Radiation Therapy Oncology Group (RTOG) Rectal Toxicity Scale for Late Complications

Risk Factors for Gastrointestinal Perforation in a Patient Being Treated with Erlotinib (Tarceva)

Tracheoesophageal Fistula Associated with Chemoradiation and Bevacizumab Therapy for Lung Cancer

Cord Colitis Syndrome of Herrera et al in a Patient Who Has Received a Stem Cell Transplant Using Cord Blood

Risk Factors of Atsumi et al for Esophageal Stenosis Following Radiotherapy for Esophageal Cancer

Score of Dranitsaris et al for Predicting Severe Diarrhea Following Chemotherapy for Colorectal Carcinoma

RTOG/EORTC Criteria for Hepatic Complications from Irradiation

SOMA-LENT Scoring of Hepatic Complications to Cancer Therapy

Common Toxicity Criteria (CTC) for Hepatic Adverse Events Associated with Cancer Therapy

Clinical Features of the Sinusoidal Obstruction Syndrome (SOS, Veno-Occlusive Disease)

Risk Factors for the Sinusoidal Obstruction Syndrome (SOS, Veno-Occlusive Disease)

Risk Factors for Portal Hypertension in a Child Receiving Radiation Therapy for a Wilms Tumor

Secondary Sclerosing Cholangitis (SSC) Following Chemotherapy

Questionnaire for Bladder Symptoms After Radiation Therapy for Prostate Cancer

RTOG/EORTC Criteria for Urinary Bladder Complications to Irradiation

RTOG/EORTC Criteria for Renal Complications from Irradiation

WHO Criteria for Acute and Subacute Urinary Tract Toxic Effects from Cancer Therapy

SOMA-LENT Scoring of Renal Complications to Cancer Therapy

SOMA-LENT Scoring of Ureteral Complications Following Cancer Therapy

SOMA-LENT Scoring of Urinary Bladder and Urethral Complications Following Cancer Therapy

Common Toxicity Criteria (CTC) for Renal and Genitourinary Adverse Events Associated with Cancer Therapy

Cyclophosphamide (Cytoxan) Cystitis

Radiation Nephropathy

Subjective Urinary Symptom Questionnaire of Colombo et al in a Patient Following Therapy for Cancer of the Urinary Bladder

Risk Factors of Choi et al for Chronic Renal Disease in a Patient with an Hematopoietic Cell Transplant

Grading System of Skinner et al for Ifosfamide Nephrotoxicity

Urinary Symptom Flare Associated with Brachytherapy for Prostate Cancer

Renal Salt Wasting and Hyponatremia Associated with Chemotherapy

Questionnaire for Sexual Problems After Radiation Therapy for Prostate Cancer

SOMA-LENT Scoring of Female Sexual Dysfunction As a Complication to Cancer Therapy

SOMA-LENT Scoring of Male Sexual Dysfunction As a Complication to Cancer Therapy

SOMA-LENT Scoring of Ovarian and Female Reproductive Complications Following Cancer Therapy

SOMA-LENT Scoring of Vulvar Complications Following Cancer Therapy

SOMA-LENT Scoring of Testicular Complications Following Cancer Therapy

SOMA-LENT Scoring of Vaginal Complications Following Cancer Therapy

SOMA-LENT Scoring of Complications Involving the Uterus and Cervix Following Cancer Therapy

Common Toxicity Criteria (CTC) for Sexual and Reproductive Adverse Events Associated with Cancer Therapy

Risk Factors of Huyghe et al for Infertility Following Therapy for a Testicular Cancer

Factors of Meistrich et al Affecting the Reduction in Sperm Count for a Man Treated with Cyclophosphamide (Cytoxan)

Risk Factors Associated with Premature Ovarian Failure in a Woman Being Treated for Cancer

Risk Factors of Schover for Dyspareunia in a Woman Who Is Being Treated for Breast Cancer

Ovarian and Laboratory Findings Associated with Premature Ovarian Failure in a Woman Being Treated for Cancer

Relative Impact of Various Chemotherapy Drugs on Spermatogenesis

Risk Factors of Meirow et al for Severe Menorrhagia in a Woman with Treatment-Induced Thrombocytopenia

Penile Shortening Following Therapy for Prostate Cancer

RTOG/EORTC Criteria for Skin Complications to Irradiation

RTOG/EORTC Criteria for Late Subcutaneous Tissue Injury from Irradiation.

Grades of Local Toxicity Associated with Hyperthermic Isolated Limb Perfusion

SOMA-LENT Scoring of Skin and Subcutaneous Tissue Complications Following Cancer Therapy

SOMA-LENT Scoring of Complications in the Female Breast Following Cancer Therapy

Common Toxicity Criteria (CTC) for Dermatologic Adverse Events Associated with Cancer Therapy

Risk of Severe Injury Following Extravasation of a Chemotherapeutic Agent

Acral Erythema (Hand and Foot Syndrome, Palmar Plantar Erythrodysaesthesia Syndrome)

Grading Recommendations of Spazzapan et al for Nail Toxicity Associated with Weekly Chemotherapeutic Regimens

Cutaneous Adverse Reactions Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitors

Surgical Wound Complications Following Chemoradiation to the Head and Neck

Risk Factors of Beesley et al for Lower Extremity Lymphedema in a Woman Following Gynecological Cancer Therapy

Effect of Bevacizumab on Wound Healing

Risk Factors of Meek for Upper Extremity Lymphedema in a Woman Following Breast Cancer Therapy

Therapy with Dexrazoxane Following Extravasation of an Anthracycline

Loss of Fingerprints Following Hand and Foot Syndrome (Acral Erythema) in a Patient Treated with Capecitabine

Risk of Hair Loss Associated with Various Chemotherapeutic Agents

Risk Factors of Vowels et al for Alopecia with Poor Hair Regrowth After a Pediatric Bone Marrow Transplant (BMT)

Benign Vascular (Lymphangiomatous) Proliferations of the Skin Following Radiation Therapy for Breast Cancer

Minimizing the Burden of Chemotherapy-Associated Hair Loss on a Patient

RTOG/EORTC Criteria for Orthopedic Complications from Irradiation

Common Toxicity Criteria (CTC) for Musculoskeletal Adverse Events Associated with Cancer Therapy

SOMA-LENT Scoring of Muscle and Soft Tissue Complications Following Cancer Therapy

SOMA-LENT Scoring of Complications Involving Mature Bone Following Cancer Therapy

SOMA-LENT Scoring of Complications Involving Growing Bone Following Cancer Therapy

Algorithm of Lin et al for Prophylactic Nailing of the Femur in a Patient at Risk for Pathologic Fracture After Radiation Therapy for Soft Tissue Sarcoma in the Thigh

Tumor Flare Syndrome Following Therapy in Patients with Metastatic Carcinoma to Bone, with Common Toxicity Criteria (CTC)

Risk Factors of Strauss et al for Skeletal Complications Following Therapy for Pediatric Acute Lymphoblastic Leukemia (ALL)

Therapy-Related Risk Factors of Mandel et al for Decreased Bone Mineral Density in Pediatric Acute Lymphoblastic Leukemia (ALL)

Risk Factors of Baxter et al for Pelvic or Femoral Neck Fracture in a Woman After Pelvic Irradiation

Fascial Edema Following Chemotherapy (Pseudoscleroderma)

Nomogram of Gortzak et al for Predicting the Risk of Pathologic Fracture of the Femur Following Treatment of a Soft Tissue Sarcoma of the Thigh

Paclitaxel-Associated Myalgias and Arthralgias

SOMA-LENT Scoring of Peripheral Nerve Complications to Cancer Therapy

SOMA-LENT Scoring of Spinal Cord Complications to Cancer Therapy

SOMA-LENT Scoring of Complications Involving the Brain Following Cancer Therapy

RTOG/EORTC Criteria for Central Nervous System Complications After Irradiation

WHO Criteria for Acute and Subacute Neurotoxic Effects of Cancer Therapy in Adults

Clinical Features of Neuropathy Following Vinca Alkaloid Therapy

Common Toxicity Criteria (CTC) for Neurological Adverse Events Associated with Cancer Therapy

Radiation-Induced Dementia in a Patient Treated for Brain Metastases

Cognitive Impairment Associated with Chemotherapy (Chemo Fog, Chemo Brain)

Oxaliplatin-Specific Neurotoxic Scale (OSNS) for Peripheral Neuropathy

Ifosfamide Encephalopathy

Paclitaxel-Associated Acute Pain Syndrome (P-APS)

Radiation-Induced Brachial Plexopathy

Radiation-Associated Myelopathy

RTOG/EORTC Criteria for Ocular Complications to Irradiation

RTOG/EORTC Criteria for Complications Affecting the Ear After Irradiation

SOMA-LENT Scoring of Complications to the Ear Following Cancer Therapy

SOMA-LENT Scoring of Complications to the Eye Following Cancer Therapy

Common Toxicity Criteria (CTC) for Auditory or Hearing Adverse Events Associated with Cancer Therapy

Common Toxicity Criteria (CTC) for Ocular and Visual Adverse Events Associated with Cancer Therapy

Risk Factors for Radiation Papillopathy and Maculopathy Following Intraocular Irradiation for Choroidal Melanoma

Risk Factors for Hearing Loss Associated with Platinum-Based Chemotherapy

Risk Factors of Archer et al for Radiation Retinopathy

Clinical Features of Radiation Retinopathy

Clinical Features of Radiation Optic Neuropathy

Classification of Brock et al for Grading High-Frequency Hearing Loss in a Child Treated with Cisplatin

Prognostic Factors of Demirci et al Affecting Visual Acuity in a Patient Undergoing Chemoreduction for Retinoblastoma

Ocular Complications Following Therapy with Erlotinib (Tarceva)

Risk Factors of Frisk et al for Cataracts Following a Bone Marrow Transplant

SOMA-LENT Scoring of Thyroid Gland Complications to Cancer Therapy

SOMA-LENT Scoring of Hypothalamic-Pituitary-Adrenal Complications of Cancer Therapy

SOMA-LENT Scoring of Hypothalamic-Pituitary-Gonadal Complications in a Woman Following Cancer Therapy

SOMA-LENT Scoring of Hypothalamic-Pituitary-Gonadal Complications in a Male Following Cancer Therapy

Common Toxicity Criteria (CTC) for Endocrine Complications Associated with Cancer Therapy

Common Toxicity Criteria (CTC) for Metabolic and Laboratory Complications Associated with Cancer Therapy

Hyperammonemia Following Cytoreductive Chemotherapy

Risk Factors of Metzger et al for Hypothyroidism Following Neck Irradiation of a Pediatric Patient for Hodgkin's Disease

Risk Factors of Vogelius et al for Radiation-Induced Hypothyroidism

Hyperparathyroidism Secondary to Sunitinib Therapy

Criteria for Post-Irradiation Bone Sarcoma

Risk of Lung Cancer Following Therapy for Hodgkin's Disease

Therapy-Related Acute Myeloid Leukemia

Risk Factors of Le Deley et al for Acute Leukemia in Children Treated for a Solid Tumor

Risk Factors of Kalaycio et al for Secondary Myelodysplasia and Acute Myeloid Leukemia (AML) in a Patient Undergoing Autologous Stem Cell Transplantation for Malignant Lymphoma

Angiosarcoma or Lymphangiosarcoma Arising in a Lymphedematous Extremity (Stewart-Treves Syndrome)

Model of Le Deley et al for Predicting Acute Myeloid Leukemia or Myelodysplasia in a Woman Treated for Breast Cancer

Risk Factors of Meadows et al for Secondary Malignant Neoplasm (SMN) in a Child with a Malignancy

Risk Factors of Umansky et al for Radiation-Induced Meningiomas

Risk Factors of Boukheris et al for a Radiation-Induced Salivary Gland Carcinoma in a Patient with Hodgkin's Lymphoma

Alkylator Score of Tucker et al and Leukemia in Childhood Cancer Survivors

Risk Factors of Bjorkholm et al for Development of Myelodysplasia or Acute Myeloid Leukemia Following Therapy of a Myeloproliferative Disorder

Carcinomas of the Kidney and Urinary Tract in Patients Exposed to Radiation Events

Indications for Postoperative Radiotherapy in Patients with Cancers of the Head and Neck

Indications for External Radiation Therapy in Patients with Thyroid Cancer

Indications of Clayman et al for Postoperative Radiation Therapy in a Patient with a Squamous Cell Carcinoma of the Skin

Criteria of Suh for Selecting Radiotherapy to Treat a Brain Metastases

Stereotactic Body Radiation Therapy (SBRT) for Inoperable Early Stage Non-Small Cell Lung Cancer

Indications for Ablative Therapy with Iodine-131 in Patients with Thyroid Carcinoma

Indications and Contraindications for Radionuclide Therapy for Pain Palliation in Bone Metastases

Pain Score and Net Pain Relief Following Irradiation for the Palliation of Multiple Bone Metastases from Solid Tumors

Assessing Effectiveness of Strontium-89 Chloride for Pain Palliation in Bone Metastases

Pain Response Criteria of Chow et al for Palliative Radiotherapy of Bone Metastases

Risk Factors for Adverse Reactions to Contrast Material

Risk Factors for Nonionic Contrast Material-Induced Venous Thrombosis

Risk Factors for Radiocontrast-Induced Acute Renal Injury

Calculation of the Maximal Amount of Contrast Material That Can Be Used Without Deterioration of Renal Function

Indications for Use of Low-Osmolality Contrast Materials

Risk Equation of Mueller et al for Contrast-Associated Nephropathy in Patients Undergoing Coronary Angiography

Complications of Using Radiocontrast Material in a Patients with Eisenmenger's Syndrome

Salivary Gland Enlargement After Use of Iodide-Based Contrast Material (Iodide Mumps)

Risk Score of Mehran et al for Predicting Nephropathy Secondary to Radiocontrast After a Percutaneous Coronary Intervention

Strategy of Pannu et al for Managing a Patient with One or More Risk Factors for Contrast-Induced Nephropathy

Nephrogenic Systemic Fibrosis (Nephrogenic Fibrosing Dermatopathy) Associated with the Use of Gadolinium-Based Contrast Agents

Risk of Lung Cancer After Radon Exposure

Definitions of Radioactive Misadventures Reportable to the Nuclear Regulatory Commission

Exposure Limits for Ionizing Radiation

Radiologic Examination in Women of Child-Bearing Age

Contraindications to Magnetic Resonance Imaging (MRI)

Excretion of Radionuclides in Breast Milk

Safety Precautions for Patients Treated with I-131 Labeled Tositumomab

Hazards Associated with the Magnetic Field Generated by a Magnetic Resonance Imaging Unit

Managing a Patient with Claustrophobia or Anxiety Associated with a Magnetic Resonance Imaging (MRI) Unit

MRI-Induced Skin Burns in Patient with Tattoos

Triggering of Radiation Alarms Following the Use of a Radionuclide

Cutaneous Burn Associated with a Metal-Backed Transdermal Patch in a Magnetic Resonance Imaging (MRI) Unit

Radiation Recall Syndromes

Using Thin Layer Chromatography to Determine the Radiochemical Purity of Technetium Tc99m Sestamibi (Cardiolite)

Localization of Gastrointestinal Bleeding with Radionuclide-Tagged Erythrocyte Scintigraphy (Tagged Red Blood Cell Scan)

Tagged Red Blood Cell Scintigraphy for Identifying a Non-Enteric Source of Bleeding

Barium Embolism Following Barium Enema

Colon Perforation During Barium Enema

Postembolization Syndrome

Postablation Syndrome

Sinusoidal Obstruction Syndrome (Veno-Occlusive Disease) Following Radioembolization of a Liver Tumor

Dosing Mesna as a Urothelial Protectant in a Patient Receiving Standard Dose Ifosfamide

Dosing Amifostine (Ethyol) in a Patient Receiving Cancer Therapy

Minimizing Hypotension During an Infusion of Amifostine

Managing Hypotension During Infusion of Amifostine

Dosing Dexrazoxane in a Patient Being Treated with Doxorubicin

Dosing Dexrazoxane to Manage a Patient with Extravasation of Doxorubicin

Discontinuation of Doxorubicin and Dexrazoxane for Myocardial Dysfunction

Dosing Palifermin (Kepivance) to Reduce Oral Mucositis Associated with Hematopoietic Stem Cell Transplant (HSCT)

Risk Factors for a Significant Radiation Exposure Associated with Depleted Uranium Munitions (DUM)

Phases of Acute Polonium-210 Poisoning

Risk Factors for Internal Contamination of a Healthcare Worker Caring for a Patient with Polonium-210 Poisoning

Risk Factors of Ray-Coquard et al for Early Death Following Conventional Chemotherapy

Nomogram of Hyman et al for Predicting Cycle One Serious Drug-Related Toxicity (SDRT) in a Phase I Oncology Trial

Score of Wongso et al for Treatment-Related Mortality (TRM) in a Patient with Advanced Stage Hodgkin Disease

Immune-Related Adverse Events (irAE) Associated with the anti-CTLA-4 Antibodies Ipilimumab and Tremelimumab

Grading Criteria of Henson et al for Defecation Urgency Following Therapy for Pelvic Cancer

Clinical Indicators of Caudell et al for Severe Long-Term Dysphagia Following Radiation Therapy for Head and Neck Cancer

Risk Factors of Caudell et al for Severe Long-Term Dysphagia Following Radiation Therapy for Head and Neck Cancer

Immune-Mediated Enterocolitis Associated with Targeted Therapy with Monoclonal anti-CTLA-4 Antibodies (Ipilimumab, Tremelimumab)

Hypogonadism in a Male Patient Treated for Cancer

Rib Fracture Following Stereotactic Body Radiotherapy (SBRT) for Non-Small Cell Lung Cancer

Grading System for Rib Fracture Following Stereotactic Body Radiation Therapy (SBRT) for a Peripheral Lung Tumor

Nomogram of Taremi et al for Predicting Radiotherapy-Induced Bone Injury (RIBI) Following Stereotactic Body Radiotherapy (SBRT) for a Lung Cancer

Pain Flare Following External Beam Radiotherapy of Bone Metastases

Model of Meanwell et al for Predicting Encephalopathy in a Patient Receiving Combination Chemotherapy with Ifosfamide and Mesna

Risk Factors of Mueller et al for Stroke in Childhood Cancer Survivors Treated with Cranial and Cervical Radiation Therapy

Risk Factors of Heckl et al for Radiation-Induced Cavernous Hemangioma of the Brain

Causes of a Super Scan (Super Bone Scan)

Uridine Administration for 5-Fluorouracil (5-FU) Toxicity

Chemotherapy-Associated Steatohepatitis (CASH)

Local Tissue Injury Associated with Extravasation of Iodinated Intravenous Contrast Material

Post-Radiofrequency Ablation Syndrome (PRFAS)

Nomogram of Pond et al for Predicting a Serious Adverse Event During Cycle One of a Phase II Clinical Trial for a Molecularly Targeted Agent

Risk Factors of Khera et al for Nonmalignant Late Effects Following Hematopoietic Cell Transplant (HCT)

Nonmalignant Late Effects of Khera et al Following Hematopoietic Cell Transplant (HCT)

Criteria of Slama et al for Complete Atrioventricular Block Following Mediastinal Irradiation

Intrarectal Instillation of Dilute Formalin to Control Hemorrhagic Proctitis

Chutkan Scale for Hemorrhagic Radiation Proctitis

Endoscopic Classification of Chi et al for Chronic Radiation-Induced Proctopathy (Rectal Telangiectasia Density, RTD)

Grades of Rubbia-Brandt for Sinusoidal Dilatation in Chemotherapy-Associated Sinusoidal Dilatation

Blue Liver Syndrome (BLS)

Chemotherapy-Induced Splenic Enlargement and Perioperative Complications in Patients Undergoing Hepatic Resection of Metastatic Colorectal Cancer

Risk Factors of Riachy et al for Hemorrhagic Cystitis in Pediatric Cancer Patients

1% Alum Irrigation to Control Hemorrhagic Cystitis and Aluminum Toxicity

Intravesical Instillation of Dilute Formalin to Control Hemorrhagic Cystitis

Hyperbaric Oxygen Therapy for Management of Radiation-Induced Hemorrhagic Cystitis

Hypogonadism Associated with Crizotinib Therapy for Metastatic Adenocarcinoma of the Lung

Barium Peritonitis

Barium Appendicitis

Barium Aspiration

30-Day Readmission Rate for Chemotherapy-Related Complications

Immune-Related Adverse Events (irAE) Associated with the anti-PD-1 Antibodies

Immune-Related Adverse Events (irAE) Associated with an Anti-Tumor Vaccine

Risk Factors of Sakurada et al for Interstitial Lung Disease (ILD) Associated with Chemotherapy for Lung Cancer

Autoimmune Pneumonitis Associated with anti-PD-1 Therapy

Risk Factors of Armenian et al for Long-Term Pulmonary Function in a Patient Who Has Survived Childhood Cancer

Tracheomediastinal Fistula (TMF) Following Therapy of an Intrathoracic Tumor

Heart Dose Model of Chow et al for Predicting Risk of Congestive Heart Failure in a Childhood Cancer Survivor

Carotid Blowout Syndrome (CBS)

ABCDE Steps of Moslehi and Deininger for Preventing Cardiovascular Disease in a Patient Receiving a Tyrosin Kinase Inhibitor (TKI) for Chronic Myeloid Leukemia (CML)

Cardiac Risk Score (CRS) of Romond et al for a Cardiac Event After Adjuvant Chemotherapy

Patterns of Christianen et al for Long-Term Swallowing Dysfunction After Definitive Radiotherapy or Chemoradiation for Head and Neck Squamous Cell Carcinoma

Total Dysphagia Risk Score (TDRS) of Langendijk et al

Risk Factors of Schmeier et al for Pelvic Fracture After Radiation Therapy for Cervical Carcinoma

Paclitaxel-Induced Peripheral Neuropathy

Criteria of Black et al for Stroke-like Migraine Attacks after Radiation Therapy (SMART)

Nomogram of Hu et al for Predicting the Risk of Chemotherapy-Induced Nausea and Vomiting (CINV) in a Cancer Patient

Prognostic Factors of Han et al for a Cancer Patient Treated in a Phase 1 Clinical Trial

Model of Hosmer et al for Predicting Febrile Neutropenia (FN) During the First Cycle of Chemotherapy for Cancer

Risk Factors of Libourel et al for Arterial or Venous Thrombosis in a Patient with Acute Myeloid Leukemia (AML) Undergoing Induction Chemotherapy

Risk Factors of Vera-Llonch et al for Oral Mucositis Associated with Radiation Therapy for a Head and Neck Cancer

mTOR (Mammalian Target of Rapamycin) Inhibitor Associated Stomatitis (mIAS) Scale of Boers-Doets and Lalla

Infarction of the Tongue (Lingual Infarction) Associated with Head and Neck Radiation Therapy

Radiation Vasculopathy

Models of Dranitsaris et al for Predicting Cardiotoxicity in a Woman with Breast Cancer Who Is Treated with Doxorubicin

Prediction Score of Dranitsaris and Lacouture for Diarrhea in a Breast Cancer Patient Treated with Lapatinib and Capecitabine

Differential Diagnosis of Radiation Anoproctitis

Ovarian Function Score (OFS) of Li et al for a Premenopausal Women with Breast Cancer and Chemotherapy-Associated Amenorrhea

Risk Factors of Kanbayashi et al for Hand-Foot Skin Reaction (HFSR) Associated with Sorafenib Therapy

Prediction Score of Dranitsaris et al for Hand-Foot Skin Reaction (HFSR) in a Cancer Patient Treated with Sorafenib

Prediction Score of Dranitsaris and Lacouture for a Skin Rash in a Breast Cancer Patient Treated with Lapatinib and Capecitabine

Gemcitabine Associated Pseudocellulitis

Risk Factors for Cytarabine Neurotoxicity

Somnolence Syndrome (Hypersomnolence) Following Cranial Radiation Therapy

Nuclear Reactor Meltdown

Managing a Patient Exposed to a Nuclear Reactor Accident (Chernobyl. Other)

Severity Score of Ma et al for an Overdose of 5-Fluorouracil (5-FU)

Radiation-Associated Valvular Heart Disease

ECG Changes Associated with Chemotherapy Using 5-Fluorouracil (5-FU) or Other Antimetabolites

ECG Changes Associated with Chemotherapy Using a Taxane

ECG Changes Associated with Chemotherapy Using Tyrosine Kinase Inhibitors (TKI)

Risk Factors of Nguyen et al for Breast-Cancer Related Lymphedema (BCRL) of the Upper Extremity

Risk Factors of Kim et al for Sacral Fracture Complicating Chemoradiation for Rectal Carcinoma

International Nuclear and Radiological Event (INES) Scale

Risk Factors of Brooks et al for Chemotherapy-Related Hospitalizationin a Patient Receiving Palliative Chemotherapy

Nijmegen Nursing Mucositis Scoring System (NNMSS) of Potting et al for Oral Mucositis in Cancer Patients

MacDibbs Mouth Assessment Tool of Dibble et al for Evaluating Oral Mucositis in a Patient Receiving Radiation Therapy

Impact of Radiation Dose on a Pacemaker or Implantable Cardioverter Defibrillator (ICD) Based on the Study of Hurkmans et al

Clinical Triggers for a Dysphagia Exam in a Patient Treated for Head and Neck Cancer

Predictive Enteral Grading (PEG) Score of Poulsen et al for Acute Grade 4 Swallowing Toxicity Following Radiotherapy Alone for Stage III or IV Squamous Cell Carcinoma of the Head and Neck

Models of Christianen et al for Swallowing Dysfunction After Chemoradiation for Head and Neck Cancer: Physician-Rate Swallowing Dysfunction at 6 Months After Therapy

Models of Christianen et al for Swallowing Dysfunction After Chemoradiation for Head and Neck Cancer: Problems Swallowing Liquids

Models of Christianen et al for Swallowing Dysfunction After Chemoradiation for Head and Neck Cancer: Problems Swallowing Soft Foods

Models of Christianen et al for Swallowing Dysfunction After Chemoradiation for Head and Neck Cancer: Problems Swallowing Solid Food

Models of Christianen et al for Swallowing Dysfunction After Chemoradiation for Head and Neck Cancer: Problems Choking When Swallowing

Classification of Dische for Swallowing Toxicity After Radiation Therapy for Head and Neck Cancer

Risk Factors of Languis et al for Weight Loss and Malnutrition in a Patient Treated for Early Stage Laryngeal Cancer

Criteria of the AAPT for Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Dirty Bomb (Radiological Dispersal Explosive)

Criteria of Ferrara et al for a Patient Being Unfit for Intensive Chemotherapy for Acute Myeloid Leukemia

Criteria of Ferrara et al for a Patient Being Unfit for Nonintensive Chemotherapy for Acute Myeloid Leukemia

On Target, Off Tumor Toxicity Associated with CAR T-Cell (CART) Therapy

Acute Toxicities of Chimeric Antigen Receptor (CAR) T-Cell Therapy

Laboratory Findings of Uhl et al Predictive of Bleeding Associated with Cancer Therapy

Immune Checkpoint Inhibitor-Associated Cardiac Disease

Radiation-Associated Stenosis of the Carotid Artery

Radiation-Induced Heart Disease

Nilotinib Vasculopathy with Occlusive Atherosclerotic Disease

Model of Delobel et al for Rectal Toxicity Following Radiotherapy for Prostate Cancer

Hepatotoxicity Associated with Arsenic Trioxide Chemotherapy

Hepatotoxicity Associated with Cancer Therapy

Model of Motwani et al for Acute Kidney Injury (AKI) After the First Course of Cisplatin (C-AKI Score)

Post-Irradiation Lichen Sclerosus et Atrophicus

Risk Factors of Yamamoto et al for Severe Lymphosclerosis in the Lower Extremity Secondary to Cancer Therapy

Post-Chemotherapy Arthralgia or Arthritis (Chemotherapy-Associated Arthropathy)

CARTOX10 Score of Neelapu et al

CAR T-Cell-Related Encephalopathy Syndrome(CRES) Grading System of Neelapu et al

Endocrinopathies Associated with Immune Checkpoint Inhibitor Therapy

Risk Factors of Kaya et al for Contrast-Induced Nephropathy in a Patient Undergoing a Primary Percutaneous Coronary Intervention (PCI)

Contrast Volume to Estimated GFR Ratio for Prediction of Contrast-Induced Acute Kidney Injury

Risk Score of Fu et al for Contrast-Induced Nephropathy in an Elderly Patient Undergoing Percutaneous Coronary Intervention (PCI)

Risk Score of Gao et al for Contrast-Induced Nephropathy (CIN) After Cardiac Catheterization in Chinese Patients

Grades of Harjai et al for Contrast Nephropathy

Nomogram of Zhou et al for Predicting Contrast-Induced Acute Kidney Injury in a Patient with an Acute Myocardial Infarction Treated Invasively

Somatic Effects of Exposure to Atomic Radiation

Factors Associated with a Chronic Lymphocytic Leukemia (CLL) Patient Being Unfit for Chemotherapy

Cytarabine (ara-C) Syndrome

Dynamic Imaging Grade of Swallowing Toxicity (DIGEST)

Risk Factors of Abayomi for Cognitive Decline After Radiation Therapy for a Head and Neck Cancer

Scale for Chemotherapy-Induced Long-Term Neurotoxicity (SCIN) of Oldenburg et al

Neutrophil-to-Lymphocyte Ratio (NLR) and Other Risk Factors of Kaya et al for Contrast-Induced Nephropathy Following Primary Percutaneous Coronary Intervention (PCI)

Recommendations of Andersen to Avoid Radiocontrast Material Associated Renal Injury in a Patient with Chronic Kidney Disease

Immunotherapy-Associated Tumor Hyperprogression

Tumor Pseudoprogression Following Cancer Therapy

Tumor Pseudoresponse Following Cancer Therapy

PROACCT Score of Grant et al to Predict Acute Care After the Initiation of Systemic Cancer Therapy

Revised WCCNR Stomatitis Staging System for Chemotherapy-Induced Stomatitis

Interstitial Lung Disease Associated with Imatinib Therapy

Criteria of Sachak et al for Neutropenic Entercolitis

Xerosis (Dry Skin) Associated with Targeted Therapy

Model of Cella et al for Radiation-Induced Hypothyroidism

Reducing the Intensity of Chemotherapy in a Frail Adult

Prognostic Model of Ahn et al for Chemotherapy-Induced Febrile Neutropenia

Dental Changes Associated with Radiation Therapy for a Head and Neck Cancer

Immune-Related Pneumonitis Associated with Immune Checkpoint Inhibitors

Aortic Stenosis Following Mediastinal or Chest Radiation

Radiation Cardiomyopathy

Radiation Pericarditis

Risk Factors of Darby et al for Radiation-Associated Ischemic Heart Disease in a Woman Treated for Breast Cancer

Risk Factors of Miften et al for Radiotherapy Affecting an Implanted Cardiac Pacemaker (ICP) and Cardioverter-Defibrillator (ICD)

Aortitis Associated with Oncologic Drug Therapy

Hepatotoxicity Associated with Immune Checkpoint Inhibitors (ICI)

Clinical Features of McMahon et al for Acute Kidney Injury (AKI) in Children Following Cisplatin Therapy

Skin Toxicity Associated with Immune Checkpoint Inhibitors

Radiation-Induced Alopecia

Arthralgias or Inflammatory Arthritis Associated with Immune Checkpoint Inhibitor (ICI) Therapy

Model of Rubin et al for Predicting Neurotoxicity After Chimeric Antigen Receptor T-Cell (CART) Therapy

Patients at Risk for Developing Cataracts After Exposure to Nonionizing Radiation

Radiation-Induced Malignant Glioma Following Gamma Knife Radiosurgery for an Intracranial Arteriovenous Malformation (AVM)

Risk Factors of Lam et al for Acute Myeloid Leukemia (AML) Arising in a Survivor of Non-Hodgkin's lymphoma (NHL)

Risk Models of Tsai et al for Acute Kidney Injury Following Percutaneous Coronary Intervention (PCI): Model for Acute Kidney Injury (AKI)

Risk Models of Tsai et al for Acute Kidney Injury Following Percutaneous Coronary Intervention (PCI): Model for Acute Kidney Injury (AKI) Requiring Dialysis

Score of Brown et al for Predicting Serious Contrast-Related Renal Dysfunction After Percutaneous Coronary Intervention

Factors Impacting the Definition of Dose-Limiting Toxicity (DLT) for a Chemotherapeutic Agent

Abscopal Effect

Model of Li et al for Predicting Nasopharyngeal Necrosis Following Radiation Therapy of a Nasopharyngeal Carcinoma

Exceptional Responder to Cancer Therapy

Predictors of Moth et al for Severe Chemotherapy-Related Toxicity in an Older Adult

Risk Factors of Jagsi et al for Acute Toxicity Following Breast Radiotherapy

Excessive Myelosuppression Following Chemoradiation in Patients with Fanconi Anemia

Nomogram of Wang et al for Predicting Radiation Pneumonitis Following Radiation Therapy of Esophageal Cancer

Nomogram of Xu et al for Predicting Radiotherapy-Related Esophageal Fistula in a Patient with Esophageal Cancer

Nomogram of Gross et al for Predicting Lymphedema in a Woman Following Axillary Surgery and Radiation Therapy for Breast Cancer

Risk Factors of Park et al for Pelvic Insufficiency Fracture in a Woman with Cervical Cancer

Model of Wang et al Predicting Temporal Necrosis in a Patient with Nasopharyngeal Carcinoma Following Intensity Modulated Radiation Therapy

Model of Huang et al for Predicting Symptomatic Epilepsy in a Patient with Radiation-Induced Brain Necrosis

Autoimmune Keratitis Associated with Atexolizumab Therapy

Model of Theunissen et al for Hearing Loss Following Cisplatin Chemoradiotherapy for Head and Neck Cancer

Tamoxifen Retinopathy

Complications of Intra-Arterial Chemotherapy (IAC) for Retinoblastoma

Type 1 Diabetes Mellitus Associated with Pembrolizumab Therapy

Predictive Model of Wu et al for Imminent Death for a Patient Receiving Palliative Radiotherapy

TEACHH Model for Predicting Life Expectancy of a Patient with Metastatic Cancer Receiving Palliative Radiotherapy

NEAT Predictive Model of Kao et al for Survival of a Patient Receiving Palliative Radiotherapy

CAR T-Cell Persistent Cytopenias

Granulomatosis with Polyangiitis (GPA, Wegener's Granulomatosis) Associated with Immune Checkpoint Inhibitor Therapy

Nomogram of Feng et al for Predicting Carotid Blowout Syndrome in a Patient with a Head and Neck Cancer

Risk Factors for Fat Necrosis Following Stereotactic Partial Breast Irradiation (S-PBI) for Early-Stage Breast Cancer

Classification of Garsa et al for Fat Necrosis Following Radiation Therapy for Breast Cancer

Classification of Poti et al for Fat Necrosis Following Breast Irradiation

Maculopathy Associated with a Blood-Brain Barrier Disruption (BBBD) Chemotherapy Regimen

Tearing After Chemotherapy

Risk Factors of Demoor-Goldschmidt et al for Small Adult Height in a Childhood Cancer Survivor

Tool of Magnuson et al for Predicting Severe Toxicity in an Older Patient Following Chemotherapy for Early-Stage Breast Cancer

Risk Factors for Hemorrhage in a Patient Treated with Ibrutinib

Models of Li et al for Oral Mucositis During Chemo-Radiotherapy of Nasopharyngeal Carcinoma: Model Using Mucosal Surface Contour (MSC)

Models of Li et al for Oral Mucositis During Chemo-Radiotherapy of Nasopharyngeal Carcinoma: Model Using Oral Cavity Contour (OCC)

World Health Organization (WHO) Oral Mucositis Scale

International Society of Pediatric Oncology Boston Ototoxicity Scale of Brock et al

Model of Baek et al for Progression of Postcontrast Acute Kidney Injury in a Chronic Kidney Disease Patient

Immune Hemolytic Anemia Associated with Contrast Media

Risk Factors for Complications Following Use of Radiocontrast Material in a Patient with Sickle Cell Anemia

Thrombocytopenia Associated with Infusion of a Radiocontrast Medium

ASCO Review of Immune Checkpoint Inhibitor Complications: Infusion-Related Reaction

ASCO Review of Immune Checkpoint Inhibitor Complications: Aplastic Anemia

ASCO Review of Immune Checkpoint Inhibitor Complications: Hemolytic Anemia

ASCO Review of Immune Checkpoint Inhibitor Complications: Lymphopenia

ASCO Review of Immune Checkpoint Inhibitor Complications: Immune Thrombocytopenia Purpura (ITP)

ASCO Review of Immune Checkpoint Inhibitor Complications: TTP and HUS

ASCO Review of Immune Checkpoint Inhibitor Complications: Venous Thromboembolism

ASCO Review of Immune Checkpoint Inhibitor Complications: Acquired Hemophilia A

ASCO Review of Immune Checkpoint Inhibitor Complications: Pneumonitis

ASCO Review of Immune Checkpoint Inhibitor Complications: Cardiovascular Toxicity

CHACS-CV (Childhood & Adolescence Cancer Survivor Cardiovascular) Risk Score of Oikonomou et al

ASCO Review of Immune Checkpoint Inhibitor Complications: Colitis

ASCO Review of Immune Checkpoint Inhibitor Complications: Hepatitis

ASCO Review of Immune Checkpoint Inhibitor Complications: Renal Toxicities

ASCO Review of Immune Checkpoint Inhibitor Complications: Bullous Skin Disease

ASCO Review of Immune Checkpoint Inhibitor Complications: Skin Rash

ASCO Review of Immune Checkpoint Inhibitor Complications: Severe Cutaneous Adverse Reaction (SCAR)

ASCO Review of Immune Checkpoint Inhibitor Complications: Inflammatory Arthritis

ASCO Review of Immune Checkpoint Inhibitor Complications: Myositis

ASCO Review of Immune Checkpoint Inhibitor Complications: Polymyalgia

ASCO Review of Immune Checkpoint Inhibitor Complications: Aseptic Meningitis

ASCO Review of Immune Checkpoint Inhibitor Complications: Autonomic Neuropathy

ASCO Review of Immune Checkpoint Inhibitor Complications: Demyelinating Disease

ASCO Review of Immune Checkpoint Inhibitor Complications: Encephalitis

ASCO Review of Immune Checkpoint Inhibitor Complications: Guillain-Barre Syndrome

ASCO Review of Immune Checkpoint Inhibitor Complications: Peripheral Neuropathy

ASCO Review of Immune Checkpoint Inhibitor Complications: Episcleritis

ASCO Review of Immune Checkpoint Inhibitor Complications: Uveitis

ASCO Review of Immune Checkpoint Inhibitor Complications: Adrenal Insufficiency

ASCO Review of Immune Checkpoint Inhibitor Complications: Diabetes Mellitus

ASCO Review of Immune Checkpoint Inhibitor Complications: Pituitary Toxicity and Hypophysitis

ASCO Review of Immune Checkpoint Inhibitor Complications: Primary Hypothyroidism

ASCO Review of Immune Checkpoint Inhibitor Complications: Thyrotoxicosis

Oncology Acute Care Risk Prediction Model of Csik et al (REDUCE Score)

Chemotherapy Toxicity Risk Score (CTRS)

Predictors of Wu et al for Imminent Death of a Cancer Patient Being Evaluated for Palliative Radiotherapy

Model of Zhu et al for Predicting Neutropenia After Etoposide-Based Chemotherapy

SAVED Score of Li et al for Immunomodulatory Drug-Associated Thrombosis

FENCE Score of Aagaard et al for Predicting Febrile Neutropenia After Cancer Chemotherapy

Model of Venalainen et al for Predicting Chemotherapy-Induced Neutropenia

CSR-FENCE Score of Aagaard et al for Predicting Febrile Neutropenia During Chemotherapy Cycles 2 to 6

Thoracic Air Leak Syndrome (TALS)

Risk Factors of Said et al for Bullous Pemphigoid Following Immune Checkpoint Inhibitor Therapy

MEK Inhibitor-Associated Retinopathy (MEKAR)

Risk Factors of Keilty et al for Hearing Loss After Chemoradiation for Head and Neck or Brain Tumors in Children

Grading System of Chang and Chinosornvatana for Cisplatin Ototoxicity in Children

Nomogram of Keilty et al for Hearing Loss Following Chemoradiation for a Pediatric CNS or Head and Neck Tumor

Score of van der Velden et al for Predicting Pain Response to Palliative Radiation for Bone Metastases

Impact of Parenteral Iron on Magnetic Resonance Imaging (MRI)

Histologic Grading of Radiation Effect

Score of Sasaki et al for Predicting Survival of Intensive Chemotherapy in Acute Myeloid Leukemia (AML)

Radiation Fibrosis Syndrome (RFS)

Risk Factors for the Radiation Fibrosis Syndrome (RFS)

Toxicity of Radiation Therapy for Gynecologic Malignancy: Acute Toxicity

Toxicity of Radiation Therapy for Gynecologic Malignancy: Chronic Toxicity

Risk Factors of Moik et al for Arterial and Venous Thromboemboli in a Cancer Patient Receiving an Immune Checkpoint Inhibitor

STRIPE Algorithm of Palma et al for Radiation Pneumonitis in a Patient with Lung Cancer

Complications of Komori et al Following Radiation Therapy of Advanced Rectal Cancer

Post-Radiation Urethral Stricture

Risk Factors for Premature Ovarian Failure in a Woman Treated with Cyclophosphamide (Cytoxan)

Models of Rattay et al for Acute Skin Radiation Toxicity in the REQUITE Breast Cohort: Model for Acute Erythema

Models of Rattay et al for Acute Skin Radiation Toxicity in the REQUITE Breast Cohort: Model for Acute Desquamation

Predictors of LeBrun et al for Wound Complications Following Radiation Therapy and Surgical Resection of a Soft Tissue Sarcoma

Score of Abuhelwa et al for Predicting Hand-Foot Syndrome in a Patient Treated with Sorafenib

Risk Factors of Jarvers et al for Wound Complications Following Surgical Stabilization of Spinal Metastases

Chemotherapy-Induced Osteonecrosis

Radiation-Induced Cranial Neuropathy

Models of Fujiwara et al for Predicting Contrast-Associated Acute Kidney Injury (CA-AKI) After Percutaneous Coronary Intervention (PCI): Simple Score

Models of Fujiwara et al for Predicting Contrast-Associated Acute Kidney Injury (CA-AKI) After Percutaneous Coronary Intervention (PCI): Logistic Regression Model

Risk Score of Yang et al for Predicting Unplanned Renal Replacement Therapy (RRT) After Coronary Catheterization

Radiation Recall Pneumonitis (RRP)

Radiation Recall Dermatitis (RRD)

Risk Factors for Failure of Radioiodine Therapy for Graves' Disease

Predictors of Sharma et al for 30-Day Readmission After CAR-T Therapy

Risk Factors of Breen et al for Acute Toxicity in a Pediatric Patient Treated with Proton Radiation Therapy

CAR-HEMATOX Model of Rejeski et al for CAR T-Cell Hematologic Toxicity

Clinical Features of Radiation-Induced Sinusitis

Nomogram of Zheng et al for Radiation-Induced Sinusitis Associated with Nasopharyngeal Carcinoma

ABSDELL Model of Liu et al for Predicting Left Ventricular Ejection Fraction (LVEF) After Therapy with Trastuzumab

Model of Kang et al for Predicting Symptomatic Heart Failure in a Patient with Acute Leukemia Treated with Anthracyclines

Increased Atherosclerotic Risk Associated with Immune Checkpoint Inhibitor Therapy

Exocrine Pancreatic Insufficiency (EPI) Associated with Immune Checkpoint Inhibitor (ICI) Therapy

Risk Score of Rodrigues et al for Acute Kidney Injury in a Hematopoietic Stem Cell Transplant (HSCT) Recipient with a Hematologic Malignancy

Therapy-Related Myeloid Neoplasm Following Chimeric Antigen Receptor T-Cell Therapy (CART)

Model of Zheng et al for Predicting Contrast-Induced Nephropathy After Use of a Gadolinium-Based Agent

TM Frailty Score of Chen et al and Chemotherapy Tolerance in Multiple Myeloma

Nomogram of Raab et al for Predicting Early Mortality After Chemoradiation for Head and Neck Cancer: Definitive Therapy

Nomogram of Raab et al for Predicting Early Mortality After Chemoradiation for Head and Neck Cancer: Adjuvant Therapy

Immune Checkpoint Inhibitor (ICI, Nivolumab) Induced Myasthenia Gravis with Myositis and/or Myocarditis

Nomograms of Takeda et al for Acute Hematologic Toxicity After Radiation Therapy: Anemia

Nomograms of Takeda et al for Acute Hematologic Toxicity After Radiation Therapy: Lymphopenia

Nomograms of Takeda et al for Acute Hematologic Toxicity After Radiation Therapy: Neutropenia

CARWL Index and Radiation-Induced Tooth Loss (RITL) in a Patient with Locally Advanced Nasopharyngeal Cancer After Radical Therapy

CARWL Index and Radiation-Induced Trismus (RIT) in a Patient with Locally Advanced Nasopharyngeal Cancer After Chemoradiation

Model of Massaccesi et al for Predicting Trismus After Radiotherapy in a Patient with Head and Neck Cancer

Nomogram of Qiu et al for Predicting Radiation Pneumonitis in a Patient with Thoracic Segment Esophageal Squamous Cell Carcinoma

Predictors of van Nimwegen et al for Heart Failure in a Patient with a History of Hodgkin Lymphoma

Chemotherapeutic Agents Associated with the Capillary Leak Syndrome (CLS)

PORTLARS (Post-Radiotherapy Low Anterior Resection Syndrome Prediction) Score of Qin et al

Adverse Effects of Radiation Therapy on Nutritional Status Based on Site

Risk Factors of Sun et al for Complications in a Woman Undergoing Post-Mastectomy Breast Implant Reconstruction

Parkinsonism Associated with BCMA-Targeting CAR-T Therapy

Predictors of Peters et al for Ocular Radiation Toxicity After Brachytherapy of a Uveal Melanoma

Medical & Environmental Radiation and Complications of Cancer Therapy